227 related articles for article (PubMed ID: 2724520)
1. [Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test].
Tateishi M; Sumita S; Watanabe H; Kumeta H; Narimatsu E; Namiki A
Masui; 1989 Apr; 38(4):546-51. PubMed ID: 2724520
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Cosgrove SB; Eisele PH; Martucci RW; Gronert GA
Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848
[TBL] [Abstract][Full Text] [Related]
4. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
Glauber V; Ben Abraham R; Zweig A; Perel A
Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
[TBL] [Abstract][Full Text] [Related]
5. [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers].
Takagi A
Rinsho Shinkeigaku; 2000 May; 40(5):423-7. PubMed ID: 11002722
[TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia in the otology patient: the UCLA experience.
Wackym PA; Blackwell KE
Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
[TBL] [Abstract][Full Text] [Related]
7. [Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia].
Wang YL; Guo XY; Xu ZH; Huang YG; Luo AL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):182-6. PubMed ID: 18505122
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of malignant hyperthermia. The platelet test versus the in vitro contracture test].
Hartung E; Preis I; Engelhardt W; Krauspe R
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):471-4. PubMed ID: 1786309
[TBL] [Abstract][Full Text] [Related]
9. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
10. [In vitro diagnosis of malignant hyperpyrexia syndrome].
Eldar I; Goldberg G; Glauber V; Perel A
Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
[TBL] [Abstract][Full Text] [Related]
11. [Clinical implications of enhanced caffeine contracture in malignant hyperthermia (MH) and Duchenne muscular dystrophy (DMD)].
Takagi A; Kojima S; Araki M
Rinsho Shinkeigaku; 1989 Mar; 29(3):301-5. PubMed ID: 2752656
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia in a halothane-anesthetized horse.
Waldron-Mease E; Klein LV; Rosenberg H; Leitch M
J Am Vet Med Assoc; 1981 Nov; 179(9):896-8. PubMed ID: 7341603
[TBL] [Abstract][Full Text] [Related]
13. Screening for malignant hyperthermia susceptibility.
Anderson IL; Rawstron RE; Dunlop DJ
N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia in humans--standardization of contracture testing protocol.
Melton AT; Martucci RW; Kien ND; Gronert GA
Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia in China.
Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
[TBL] [Abstract][Full Text] [Related]
17. Halothane-caffeine contracture testing in neuromuscular diseases.
Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia in dogs.
Nelson TE
J Am Vet Med Assoc; 1991 Mar; 198(6):989-94. PubMed ID: 2032926
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
[TBL] [Abstract][Full Text] [Related]
20. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
Striebel HW; Lechner J; Wiegand C; Hartung E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
